TABLE 1.
Characterization of MSG-specific MAbs and frequency of epitope expression
MAb | Immunogena | Reactivityb
|
No. of positive plaques | ||
---|---|---|---|---|---|
P. carinii f. sp. carinii MSG | P. carinii f. sp. hominis MSG | MBPMSG41–1065 | |||
RA-F1 | Rat MSG | + | + | + | 738 |
RB-E3 | Rat Pc | + | − | + | 286 |
RA-C6 | Rat MSG | + | − | − | 46 |
RB-C8 | Rat Pc | + | + | − | 112 |
RB-2F9 | Rat Pc | + | + | − | 307 |
HB-G6 | Human Pc | + | + | − | 3 |
RA-C7 | Rat MSG | + | − | − | 23 |
RA-C1 | Rat MSG | + | − | − | 55 |
RA-C11 | Rat MSG | + | − | − | 6 |
RB-F8 | Rat Pc | + | − | − | 7 |
RA-G10 | Rat MSG | + | + | + | NDc |
RA-E7 | Rat MSG | + | + | + | ND |
Rat MSG, P. carinii f. sp. carinii MSG purified by electroelution from an SDS-polyacrylamide gel; Rat Pc, SDS-solubilized P. carinii f. sp. carinii; Human Pc, SDS-solubilized P. carinii f. sp. hominis.
Determined by immunoblotting reactivity.
ND, not done.